RGNX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

RGNXRegenxbio Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

RGNXRegenxbio Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RGNX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±56.0%▼−4.28%×0.08

Q2 FY26±18.2%▲+7.43%×0.41

May 14 '26±32.5%▼−37.80%×1.16

Q1 FY26±42.1%▼−4.60%×0.11

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

= impliedRGNX realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 56%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

RGNXRegenxbio Inc.

7.62▲+3.23%· post 7.62

Mkt cap$503.9MRevenue$9MQ3 FY26Revenue$170MFY25

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

RGNXRegenxbio Inc.

AMGNAmgen Inc

7.62▲+3.23%post 7.62

Price

460.55▲+0.06%post 460.42

$503.9M

Mkt cap

$249.0B

Q3 FY26$9M

Revenue

$10.4BQ3 FY26

FY25$170M

Revenue

$36.8BFY25

RGNX7.62▲+3.23%vsAMGN460.55▲+0.06%ClosedNov 6 '26